📰 Heart Failure Program News
Page 3 - Heart Failure Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Heart Failure Program. Real-time updates on events, politics, business and more.
January 8, 2024
Tufts Medical Center announced Monday that it completed 61 adult heart transplants in 2023, breaking its own regional record and becoming the first-ever center in New England to reach that benchmark in one calendar year, officials said.
November 14, 2023
A spokesperson said it is the only hospital in the state with a comprehensive heart failure center.
November 8, 2023
Maui Memorial Medical Center has again earned the distinguished Gold Plus and Target: Honor Roll Quality Achievement Awards from American Heart Association’s Get With The Guidelines program for excellence in heart and stroke care. The national awards recognize MMMC’s demonstrated commitment to following up-to-date, research-based guidelines for treating heart disease and stroke, ultimately leading to more lives […]
October 18, 2023
Conference sessions will focus on the latest advancements and trends in cardiovascular medicine as well as best practices for managing and leading cardiology programs.
October 18, 2023
/PRNewswire/ -- During its annual board of directors meeting, members of the Florida Health Sciences Center board elected Drew Graham as chair. Graham succeeds...
October 11, 2023
RAPID CITY, S.D. – Monument Health Heart and Vascular Institute will be extending its cardiac services to include treatment for advanced heart failure. This includes a partnership with the University
August 18, 2023
HARTSVILLE, S.C. — Carolina Pines Regional Medical Center was recently one of 153 hospitals included in the 2023 Becker’s Hospital Review listing of “Great Community Hospitals.” Carolina Pines was one
August 3, 2023
Born with a rare birth defect that affected his heart, Levi had a heart transplant at Johns Hopkins All Children’s. Now in first grade, he has received specialized care from experts throughout the hospital.
July 24, 2023
A multipart, phase 1 trial provides evidence demonstrating the safety of zilbesarian, an RNA interference agent, which appeared to have a favorable safety profile among adult patients with hypertension.
July 20, 2023
THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack